CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹1,793 Cr | ₹1,634 Cr | ₹1,303 Cr | ₹1,242 Cr | ₹1,096 Cr |
What is the latest Short Term Provisions ratio of CIPLA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹1,793 Cr |
| Mar2024 | ₹1,634 Cr |
| Mar2023 | ₹1,303 Cr |
| Mar2022 | ₹1,242 Cr |
| Mar2021 | ₹1,096 Cr |
How is Short Term Provisions of CIPLA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,793 Cr | 9.77 | |
| Mar2024 | ₹1,634 Cr | 25.36 | |
| Mar2023 | ₹1,303 Cr | 4.96 | |
| Mar2022 | ₹1,242 Cr | 13.25 | |
| Mar2021 | ₹1,096 Cr | - | |
Compare Short Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹107,687.8 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| MANKIND PHARMA | ₹92,377.5 Cr | 1.5% | 8.7% | -5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.6% |
0.2% |
-5.4% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses